
If you have searched "is ashwagandha good for anxiety," you are not alone. Ashwagandha (Withania somnifera) is one of the most widely discussed herbal supplements for stress and anxiety, and interest in it has grown sharply over the past several years. But popularity does not equal proof. Here is what the clinical research actually suggests about ashwagandha and anxiety, including where the evidence is encouraging and where it falls short.
The leading hypothesis centers on the hypothalamic-pituitary-adrenal (HPA) axis, the hormonal cascade that governs your body's stress response. When the HPA axis is chronically activated, cortisol levels remain elevated, contributing to persistent feelings of anxiety, disrupted sleep, and physiological tension.
Ashwagandha appears to modulate this pathway. Its bioactive compounds, primarily withanolides, may dampen HPA axis overactivity and reduce circulating cortisol. There is also preliminary evidence that ashwagandha interacts with GABAergic receptors, the same inhibitory neurotransmitter system targeted by benzodiazepines, though through a much milder mechanism.
It is worth noting that these mechanisms are not fully mapped. Most mechanistic data comes from animal models, and the precise way ashwagandha influences human neurobiology remains an area of active research.
Several randomized controlled trials have examined ashwagandha for anxiety and stress, and the results have generally been positive, though with important caveats.
The Chandrasekhar 2012 study is among the most frequently cited. In this 60-day trial, 64 adults with a history of chronic stress were randomized to receive either 300 mg of a high-concentration full-spectrum ashwagandha root extract twice daily or a placebo. The ashwagandha group showed a statistically significant reduction in serum cortisol levels compared to placebo, along with substantially lower scores on all assessed stress scales.
A 2019 study by Lopresti and colleagues found that adults taking 240 mg of ashwagandha extract daily for 60 days reported significant reductions in anxiety (measured by the Hamilton Anxiety Rating Scale) compared to placebo. Cortisol levels in the ashwagandha group decreased as well.
A systematic review of multiple trials has broadly supported these findings, suggesting that ashwagandha supplementation is associated with modest-to-moderate reductions in anxiety and stress markers in adult populations. However, most individual trials are relatively small, short in duration, and often funded by supplement manufacturers, which warrants caution when interpreting the results.
It would be misleading to frame ashwagandha as a direct alternative to prescription anxiety medications. SSRIs, SNRIs, and benzodiazepines operate through well-characterized pharmacological mechanisms, are supported by large-scale clinical trials, and are prescribed under medical supervision for diagnosed anxiety disorders.
Ashwagandha, by contrast, is classified as a dietary supplement. Its effects appear milder, its optimal dosing is less standardized, and it has not been evaluated by regulatory agencies for the treatment of any anxiety disorder. For individuals with moderate-to-severe generalized anxiety disorder, panic disorder, or social anxiety, evidence-based pharmaceutical and psychotherapeutic interventions remain the standard of care.
That said, some clinicians view ashwagandha as a potential complement to, not replacement for, conventional treatment, particularly for individuals experiencing subclinical stress or mild anxiety symptoms. Any decision to add a supplement should involve your healthcare provider, especially if you are already taking medication.
Most clinical trials showing benefit have used standardized ashwagandha root extracts in the range of 300 to 600 mg per day, typically divided into two doses. Look for products standardized to withanolide content, such as KSM-66 or Sensoril, which are the extract forms most commonly used in research.
Not everyone should take ashwagandha. It is generally contraindicated during pregnancy, and individuals with autoimmune thyroid conditions (such as Hashimoto's or Graves' disease) should exercise particular caution, as ashwagandha may influence thyroid hormone levels. Those taking sedatives, immunosuppressants, or thyroid medications should consult a physician before starting supplementation. For a more detailed look at potential risks, see our guide to ashwagandha side effects and safety.
The evidence suggests that ashwagandha may offer modest anxiety-reducing benefits, particularly through cortisol modulation and HPA axis regulation. However, it is not a proven treatment for clinical anxiety disorders, and it should not replace professional care. If you are considering ashwagandha, talk with your provider about whether it makes sense as part of a broader approach to managing stress and anxiety.